Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RYOAX vs. IBB: which is better?

Bottom line

RYOAX vs IBB: the short answer

RYOAX (Biotechnology Fund) and IBB (iShares Biotechnology ETF) are both mutual funds.

But IBB is far broader, holding 254 positions to 74 for RYOAX, so beyond the top names it adds exposure RYOAX doesn't have.

IBB is cheaper at 0.44% vs 1.63% — a difference of $119 a year per $10,000 invested.

Over five years, RYOAX returned +3.8% a year vs +2.5% for IBB.

Updated Nov 19, 2026

RYOAX vs IBB side by side

RYOAXIBB
TypeMutual fundETF
Fund familyGuggenheimiShares
CategoryTechnology SectorTechnology Sector
Expense ratio1.63%0.44%
Annual cost per $10k$163$44
10-yr cost on $10k (prospectus)$1,983$555
Max front load—None
12b-1 fee0.25%0%
1-yr return+30.4%+28.0%
5-yr return (annualized)+3.8%+2.5%
10-yr return (annualized)+5.6%+4.4%
Best quarter—+26.8%
Worst quarter—−22.9%
Net assets (fund)$136.8M$5.9B
Number of holdings74254
Portfolio turnover75%27%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

16 of RYOAX's top 25 holdings also appear in IBB's top 25.

Shared top holdings
HoldingRYOAXIBB
Amgen Inc5.05%7.50%
Gilead Sciences Inc4.49%7.52%
Vertex Pharmaceuticals Inc4.32%7.66%
Regeneron Pharmaceuticals Inc2.93%5.70%
Alnylam Pharmaceuticals Inc2.36%5.68%
Beone Medicines Ltd2.17%2.11%
Moderna Inc2.15%0.88%
Biogen Inc2.13%2.03%
Natera Inc2.12%2.11%
Illumina Inc1.94%1.41%
Insmed Inc1.79%2.95%
United Therapeutics Corp1.72%1.82%
Incyte Corp1.62%1.62%
Neurocrine Biosciences Inc1.52%1.34%
Argenx Se1.48%3.15%

Source: SEC Form N-PORT

RYOAX top 10

  1. Abbvie Inc — 8.17%
  2. Amgen Inc — 5.05%
  3. Gilead Sciences Inc — 4.49%
  4. Vertex Pharmaceuticals Inc — 4.32%
  5. Regeneron Pharmaceuticals Inc — 2.93%
  6. Revolution Medicines Inc — 2.48%
  7. Alnylam Pharmaceuticals Inc — 2.36%
  8. Beone Medicines Ltd — 2.17%
  9. Moderna Inc — 2.15%
  10. Biogen Inc — 2.13%

IBB top 10

  1. BlackRock Funds III — 13.18%
  2. Vertex Pharmaceuticals, Inc. — 7.66%
  3. Gilead Sciences, Inc. — 7.52%
  4. Amgen, Inc. — 7.50%
  5. Regeneron Pharmaceuticals, Inc. — 5.70%
  6. Alnylam Pharmaceuticals, Inc. — 5.68%
  7. IQVIA Holdings, Inc. — 3.18%
  8. Argenx SE — 3.15%
  9. Insmed, Inc. — 2.95%
  10. Mettler-Toledo International, Inc. — 2.49%

FAQ

What is the difference between RYOAX and IBB?
RYOAX (Biotechnology Fund) and IBB (iShares Biotechnology ETF) are both mutual funds. But IBB is far broader, holding 254 positions to 74 for RYOAX, so beyond the top names it adds exposure RYOAX doesn't have.
Which is cheaper, RYOAX or IBB?
IBB has the lower expense ratio (0.44%).
Should I own both RYOAX and IBB?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.